PTEN and non-small cell lung carcinoma: Expression of miR-130 is lower in both non-small cell lung cancer (NSCLC) cell lines and tissues, and miR-130 overexpression results in cell growth inhibition and enhanced cell apoptosis, through increasing PTEN levels in NSCLC, thus miR-130 acts as a tumour suppressor in this context [98].